SUDEEPPHRM
NSESudeep Pharma Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹749.50
19.70 (2.70%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹8.47K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹524.05+43.0%
52W High₹816.35-8.2%
Current Price
₹749.50
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹674.55
Upper Circuit₹824.45
Reference Price
₹749.50
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹704.6
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹851.95
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bullish (price down, volume up)
Composite score 39.57 (BUY) with 87.6% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
88%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
720.71
EMA50
687.62
Price Action
DOWNTREND
BEARISH
Higher Highs3
Higher Lows3
Lower Highs6
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹816.35
Support (Below)
₹728.00
₹705.50
₹688.00
₹662.50
₹653.55
Volume Analysis
TrendINCREASING
Change+73.10%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹742.00
3% Risk₹727.01
5% Risk₹712.02
7% Risk (Custom)
₹697.03Technical Levels
1x ATR (Volatility)₹714.59
2x ATR (Swing)₹679.68
3x ATR (Trend)₹644.77
Immediate Support₹728.00
Moving Averages
EMA 9 (Short-term)₹738.13
EMA 20 (Medium-term)₹720.71
EMA 50 (Trend)₹687.62
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹115.5 Cr | ₹153 Cr | ₹124.2 Cr | ₹172.3 Cr |
| Net Profit | ₹28.7 Cr | ₹44.1 Cr | ₹30.8 Cr | ₹47.5 Cr |
| EPS | ₹2.54 | — | ₹2.73 | ₹4.29 |
| Operating Profit | ₹41.7 Cr | ₹61.3 Cr | ₹48.5 Cr | ₹66.8 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SUDEEPPHRM
View All
positive
Business Standard - Markets 12d ago
Stocks to buy today: Sudeep Pharma, Rubicon Research, ICICI Prudential AMC
Stocks to buy today: Aakash Shah of Choice Broking has recommended buying three stocks today - Rubicon Research, Sudeep Pharma, and ICICI Prudential Asset Management.
AAKASHALPL30IETFAUTOIETFBANKIETFBSE500IETFCASHIETFCHOICEINCOMMOIETFCONSUMIETFCRAMCEVIETFFINIETFFMCGIETFGOLDIETFGSEC10IETFGSEC5IETFHDFCAMCHEALTHIETFICICIAMCICICIB22ICICIPRULIINFRAIETFITIETFJAROLIQUIDIETFLOWVOLIETFMETALIETFMIDCAPIETFMIDSELIETFMOM30IETFNAM-INDIANEXT50IETFNIF100IETFNIFTYIETFNV20IETFOILIETFPSUBNKIETFPVTBANIETFQUAL30IETFRUBICONSENSEXIETFSHAHSILVERIETFSPARCSUDEEPPHRMTOP15IETFUTIAMCVAL30IETFCapital GoodsConsumer Services
NEWS
positive
Business Standard - Markets 22d ago
Sudeep Pharma consolidated net profit rises 10.61% in the March 2026 quarter
Sales rise 15.73% to Rs 182.34 crore
SUDEEPPHRMHealthcare
positive
Moneycontrol NaNd ago
Reduce Sudeep Pharma; target of Rs 627: Prabhudas Lilladher
Prabhudas Lilladher recommended reduce rating on Sudeep Pharma with a target price of Rs 627 in its research report dated May 22, 2026.
SPARCSUDEEPPHRMHealthcare